Addiction Toxicology Case Conference - January 2023

A Discussion of Pediatric Cannabis Ingestions and a Case Involving a Patient Admitted to a Research Unit

Case 1: Beyond Colorado - discussion of pediatric cannabis ingestions trends and clinical presentation
Case 2: An Alcohol Use Disorder (AUD) inpatient study participant develops altered mental status the week after admission to the locked clinical research unit. 

Learner Objectives:

1. Review the current emerging literature investigating pediatric cannabis exposure, including risk factors for severe outcomes, differences between inhalational and edible exposure, and signs and symptoms of exposure in pediatric patients. 
2. Consider the management and workup of pediatric patients exposed to cannabis.
3. Discuss the possibility of a cannabis withdrawal state and next steps for investigating this phenomenon. 

Panelists

Jeffrey Brent, MD, PhD, FACMT, Distinguished Clinical Professor of Medicine and Emergency Medicine, University of Colorado Schools of Medicine and Public Health, Denver, CO
Stephanie T. Weiss, MD, PhD, Staff Research Physician, Translational Addiction Medicine Branch, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health

Series Moderators

Timothy J. Wiegand, MD, FACMT, DFASAM (ACMT/ASAM Expert), Director of Toxicology and of the Toxicology Consult Service, University of Rochester Medical Center, Rochester, NY 
Gloria J. Baciewicz, MD (ASAM Expert), Addiction Psycharcist, Strong Recovery; Professor of Clinical Psychiatry, Department of Psychiatry, University of Rochester Medical Center, Rochester, NY

None of the planners or faculty for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All of the relevant financial relationships listed for these individuals have been mitigated.

Continuing Education

Continuing Education credit for this activity is provided by AKH Inc., Advancing Knowledge in Healthcare. Credits are available for Physicians and Nurses. For more info, click here.

CE: 1.25

About The Series: The ACMT/ASAM Addiction Toxicology Case Conference webinar series discusses Addiction/Toxicology cases in an interactive fashion featuring experts from Addiction Medicine, Addiction Psychiatry, and Medical Toxicology.

This webinar is open to the public.

Continuing Education credits are now available for this activity! Click here for more info.

Continuing Education

Continuing Education credit for this activity is provided by AKH Inc., Advancing Knowledge in Healthcare.

In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and American College of Medical Toxicology (ACMT). AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This activity was planned by and for the healthcare team, and learners will receive 1.25 Interprofessional Continuing Education (IPCE) credit for learning and change.

Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this live virtual activity and enduring activity material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. For physicians, hours of participation are the number of AMA PRA Category 1 Credit(s)™ awarded.

Nurses
Credit being awarded:1.25 ANCC contact hours.

Criteria for Success 
To obtain a certificate of completion, a score of 70% or better on the post-test is required. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the evaluation, and have received a digital copy of your certificate. You must participate in the entire activity to receive credit. If you have questions about this activity, please contact AKH Inc. at kwolynski@akhcme.com 

Commercial Support
There is no commercial support for this activity.

Timothy J. Wiegand, MD, FACMT, DFASAM, Lead Physician Planner/Reviewer/Faculty: has nothing to disclose.
Gloria J. Baciewicz, MD, Physician Planner/Reviewer/Faculty: has nothing to disclose.
Jeffrey Brent, MD, PhD, Faculty: has nothing to disclose.
Stephanie Weiss, MD, PhD, Faculty: has nothing to disclose.
ACMT Staff and Planners: have nothing to disclose.

Dorothy Caputo, MA, BSN, RN, Lead Nurse Planner/Reviewer: has nothing to disclose.
Michele Bielarski, RN, Nurse Planner/Reviewer: has nothing to disclose.
AKH Planners and Reviewers: have nothing to disclose.

None of the planners or faculty for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All of the relevant financial relationships listed for these individuals have been mitigated.

Disclosures
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.

Disclosure of Unlabeled Use and Investigational Product 
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer 
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to optout@akhcme.comwith your information with "Opt Out" in the subject line.

Read Full Disclosure